$SRNE buyout $7 per share Sorrento Therapeutics,
Post# of 72708
Sorrento Therapeutics, Inc. Sorrento or the Company), announced today that on January 9, 2020 , it received a non-binding proposal from a private equity fund to acquire a majority or all of the issued and outstanding shares of the Company for up to $7.00 per share.